Edition:
United Kingdom

CTI Biopharma Corp (CTIC.OQ)

CTIC.OQ on NASDAQ Stock Exchange Capital Market

1.36USD
13 Dec 2018
Change (% chg)

$-0.12 (-8.11%)
Prev Close
$1.48
Open
$1.56
Day's High
$1.56
Day's Low
$1.35
Volume
50,115
Avg. Vol
59,009
52-wk High
$5.36
52-wk Low
$1.35

Chart for

About

CTI BioPharma Corp. (CTI), formerly Cell Therapeutics, Inc., is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers. The Company is focused on commercializing PIXUVRI... (more)

Overall

Beta: 0.62
Market Cap(Mil.): $140.98
Shares Outstanding(Mil.): 42.98
Dividend: --
Yield (%): --

Financials

  CTIC.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -1.80 -- --
ROI: -85.83 9.01 14.96
ROE: -127.14 10.15 16.52

Earnings vs. Estimates